Specifically, the expression of ACSL4 is significantly upregulated in multiple types of cancer, including breast ER negative, colorectal, and prostate, while it becomes downregulated in other cancers (breast cancer ER positive, lung cancer and cervical cancer). Here, ESR1 is linked to breast cancer.